Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8016638 | 0.89 | MAOA (0.57) | BRD4HSD17B10MEN1KMT2ACYP2A6 | |
| SCHEMBL8359592 | 0.89 | HPGD (0.51) | HSD17B10MEN1KMT2ACYP2A6ALDH1A1 | |
| SCHEMBL9576677 | 0.80 | HPRT1 (0.50) | HSD17B10MEN1KMT2ACYP2A6ALDH1A1 | |
| SCHEMBL9181184 | 0.78 | KDM4E (0.49) | HSD17B10MEN1KMT2ACYP2A6ALDH1A1 | |
| SCHEMBL29862069 | 0.78 | KDM4E (0.49) | HSD17B10MEN1KMT2ACYP2A6ALDH1A1 | |
| SCHEMBL8713855 | 0.74 | HPGD (0.46) | HSD17B10MEN1KMT2ACYP2A6ALDH1A1 | |
| SCHEMBL8713852 | 0.74 | HPGD (0.46) | HSD17B10MEN1KMT2ACYP2A6ALDH1A1 | |
| SCHEMBL20457151 | 0.74 | PIM1 (0.38) | BRD4HSD17B10MEN1KMT2ACYP2A6 | |
| SCHEMBL15467504 | 0.73 | CYP1A2 (0.46) | HSD17B10MEN1KMT2ACYP2A6ALDH1A1 | |
| SCHEMBL30994678 | 0.73 | HSP90AA1 (0.59) | BRD4HSD17B10ALDH1A1MAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3630759-A1 | ION CHANNEL INHIBITOR COMPOUNDS FOR CANCER TREATMENT | Centre National De La Recherche Scientifique (FR) | 2020-04-08 | — | — | EP | disclosed |
| EP-3328872-B1 | ELECTROLUMINESCENT BRIDGED METAL COMPLEXES FOR USE IN ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2019-05-29 | — | — | EP | disclosed |
| US-20180226591-A1 | ELECTROLUMINESCENT BRIDGED METAL COMPLEXES FOR USE IN ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2018-08-09 | — | — | US | disclosed |
| US-20180226591-A1 | ELECTROLUMINESCENT BRIDGED METAL COMPLEXES FOR USE IN ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2018-08-09 | — | — | US | disclosed |
| EP-3328872-A1 | ELECTROLUMINESCENT BRIDGED METAL COMPLEXES FOR USE IN ELECTRONIC DEVICES | Merck Patent GmbH (DE) | 2018-06-06 | — | — | EP | disclosed |
| US-7332260-B2 | Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO)polymer matrices containing them | CORNING INCORPORATED (US) | 2008-02-19 | — | — | US | disclosed |
| US-7332260-B2 | Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO)polymer matrices containing them | CORNING INCORPORATED (US) | 2008-02-19 | — | — | US | disclosed |
| EP-1100769-B1 | AMINOMETHYLCARBOXYLIC ACID DERIVATIVES | AKZO NOBEL NV (NL) | 2002-12-04 | — | — | EP | disclosed |
| US-6410592-B1 | THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS | AKZO NOBEL N.V. (NL) | 2002-06-25 | — | — | US | disclosed |
| EP-0864559-B1 | Substituted amino compounds and their use as analgesic active substances | GRUENENTHAL GMBH (DE) | 2002-06-05 | — | — | EP | disclosed |
| WO-1996005195-A1 | NOVEL N-SUBSTITUTED NAPHTHOFUSED LACTAMS | NOVO NORDISK A/S (DK) | 1996-02-22 | — | — | WO | disclosed |
| US-5356935-A | Reductase inhibitors | ELI LILLY AND COMPANY (US) | 1994-10-18 | — | — | US | disclosed |
| US-5356935-A | Reductase inhibitors | ELI LILLY AND COMPANY (US) | 1994-10-18 | — | — | US | disclosed |
| US-5326863-A | Antithrombin and antitrypsin activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-07-05 | — | — | US | disclosed |
| US-5256293-A | Immobilizing enantiomer on support effective for use in chromatographic separation | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-10-26 | — | — | US | disclosed |
| WO-1992019589-A2 | LIPOXYGENASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1992-11-12 | — | — | WO | disclosed |
| US-5140047-A | Antiinflammatory agents | SMITHKLINE BEECHAM CORPORATION (US) | 1992-08-18 | — | — | US | disclosed |
| US-4886733-A | Photographic products and processes | POLAROID CORPORATION (US) | 1989-12-12 | — | — | US | disclosed |
| EP-0097940-B1 | PROCESS FOR THE PREPARATION OF ARALIPHATIC ALCOHOLS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-04-24 | — | — | EP | disclosed |
| EP-0097940-A1 | Process for the preparation of araliphatic alcohols | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-01-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180226591-A1 | ELECTROLUMINESCENT BRIDGED METAL COMPLEXES FOR USE IN ELECTRONIC DEVICES | EED, SOD1, NBAS | BRD4 475/4885HSD17B10 2679/4885MEN1 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.